0001127602-18-000541.txt : 20180103 0001127602-18-000541.hdr.sgml : 20180103 20180103155634 ACCESSION NUMBER: 0001127602-18-000541 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180102 FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith David Ross CENTRAL INDEX KEY: 0001650274 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15943 FILM NUMBER: 18505109 MAIL ADDRESS: STREET 1: 251 BALLARDVALE STREET CITY: WILMINGTON STATE: MA ZIP: 01887 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CHARLES RIVER LABORATORIES INTERNATIONAL INC CENTRAL INDEX KEY: 0001100682 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 061397316 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 BUSINESS PHONE: 781-222-6000 MAIL ADDRESS: STREET 1: 251 BALLARDVALE ST CITY: WILMINGTON STATE: MA ZIP: 01887 FORMER COMPANY: FORMER CONFORMED NAME: CHARLES RIVER LABORATORIES HOLDINGS INC DATE OF NAME CHANGE: 19991208 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2018-01-02 0001100682 CHARLES RIVER LABORATORIES INTERNATIONAL INC CRL 0001650274 Smith David Ross 251 BALLARDVALE STREET WILMINGTON MA 01887 1 Corporate Executive VP & CFO Common Stock 2018-01-02 4 S 0 600 110.30 D 14171 D Common Stock 2018-01-02 4 S 0 200 110.31 D 13971 D Common Stock 2018-01-02 4 S 0 300 110.35 D 13671 D Common Stock 2018-01-02 4 S 0 300 110.36 D 13371 D Common Stock 2018-01-02 4 S 0 100 110.37 D 13271 D Common Stock 2018-01-02 4 S 0 300 110.38 D 12971 D Common Stock 2018-01-02 4 S 0 100 110.385 D 12871 D Common Stock 2018-01-02 4 S 0 100 110.39 D 12771 D Common Stock 2018-01-02 4 S 0 100 110.40 D 12671 D Common Stock 2018-01-02 4 S 0 300 110.42 D 12371 D Common Stock 2018-01-02 4 S 0 100 110.43 D 12271 D Common Stock 2018-01-02 4 S 0 100 110.45 D 12171 D Common Stock 2018-01-02 4 S 0 100 110.475 D 12071 D Common Stock 2018-01-02 4 S 0 200 110.50 D 11871 D Common Stock 2018-01-02 4 S 0 200 110.53 D 11671 D This sale occurred pursuant to a 10b5-1 Trading Plan. /s/ David R. Smith 2018-01-02